Advertisement
OtherMinireview

Emerging Roles of Uremic Toxins and Inflammatory Cytokines in the Alteration of Hepatic Drug Disposition in Patients with Kidney Dysfunction

Hiroshi Arakawa and Yukio Kato
Drug Metabolism and Disposition February 28, 2023, DMD-MR-2022-000967; DOI: https://doi.org/10.1124/dmd.122.000967

Article Information

DMD-MR-2022-000967
DOI 
https://doi.org/10.1124/dmd.122.000967
PubMed 
36854605
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Published online February 28, 2023.

Article Versions

Copyright & Usage 
Copyright © 2023 American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Hiroshi Arakawa1 and
  2. Yukio Kato1,*
  1. 1Faculty of Pharmacy, Kanazawa University, Japan
  1. ↵* Corresponding Author:
    Yukio Kato, Faculty of Pharmacy, Kanazawa University, Kakuma-machi, Kanazawa, N/A, 920-1192, Japan. E-mail: ykato{at}p.kanazawa-u.ac.jp

Statistics from Altmetric.com

Article usage

Article usage: February 2023 to December 2024

AbstractFullPdf
Feb 20233612
Mar 20232507106
Apr 202365029
May 202387028
Jun 202356024
Jul 202366025
Aug 20237843294
Sep 202328693119
Oct 2023167755
Nov 2023134532
Dec 2023185327
Jan 2024224227
Feb 20249067
Mar 2024132128
Apr 20247287
May 2024691411
Jun 2024105411
Jul 20247467
Aug 2024201653
Sep 2024192228
Oct 2024583818
Nov 202434222
Dec 2024387

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

OtherMinireview

Hepatic Drug Disposition in Patients with Kidney Dysfunction

Hiroshi Arakawa and Yukio Kato
Drug Metabolism and Disposition February 28, 2023, DMD-MR-2022-000967; DOI: https://doi.org/10.1124/dmd.122.000967
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement